Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287918
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-02-22
Brief Title:
A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
Sponsor:
3H Suzhou Pharmaceuticals Co Ltd
Organization:
3H Suzhou Pharmaceuticals Co Ltd
Organization Data
Organization:
3H Suzhou Pharmaceuticals Co Ltd
Class:
INDUSTRY
Study ID:
3HP-2827-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
3H Suzhou Pharmaceuticals Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None